InfuSystem (INFU): Rentabilitas operasi

InfuSystem Inc (INFU) - logo korporat

The quarterly operating margin of InfuSystem Holdings (INFU) demonstrates revenue resilience, bolstered by the defensive qualities of the healthcare sector and an independent product cycle. High profitability is based on the pump rental service model and long-term agreements with hospitals. Current indicators rely on oncology treatment volumes and government price regulation. The value of 9.80 expresses the metric level, visualizing the efficiency of the company's core operations.

INFU - Rasio bathi operasi InfuSystem Inc ing rentang 04.07.2022 - 19.11.2026

INFU (InfuSystem Inc): rincian analitis lan laporan miturut indikator

- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
Analisis umum perusahaan:infusystem.com, INFU
Produk dadi InfuSystem

A conservative approach requires separating real efficiency from market noise. The stability of InfuSystem Holdings (INFU) is based on recurring payments for pump rentals and consumables. Analyzing the core margin chart, an investor can see the share of operating profit before interest and taxes in revenue. This indicator measures the business's ability to generate cash flow without considering financial leverage. Growth in this metric confirms the fundamental strengthening of the asset's value.

Karo sapa InfuSystem Holdings saingan

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|Margin dodolan operasi TKNO|Margin operasi monogramorthopedics.com|Margin dodolan operasi STSS (Sharps Technology, Inc.)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi